financetom
Business
financetom
/
Business
/
What's Going On With Amazon Stock Today?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Amazon Stock Today?
Jun 24, 2025 9:27 AM

Amazon.com Inc ( AMZN ) shares are trading higher. The company on Tuesday announced a planned expansion of same-day and next-day delivery.

What Happened: Amazon ( AMZN ) said it plans to accelerate delivery speeds for tens of millions of U.S. customers in more than 4,000 smaller cities and rural communities by the end of 2025.

The e-commerce giant will invest over $4 billion in an effort to triple the size of its delivery network by the end of 2026. Amazon ( AMZN ) plans to transform existing rural delivery stations into hybrid hubs that serve multiple functions and use machine learning to better predict what customers will want to order to help optimize inventory.

“Everybody loves fast delivery. So, whether you live in Monmouth, Iowa or in downtown Los Angeles, now you’re going to have the same fantastic Amazon ( AMZN ) customer experience: the ability to get the wide variety of items you need to keep your household running every day, delivered the same or next day,” said Doug Herrington, CEO of Worldwide Amazon Stores.

The planned expansion includes Amazon’s everyday essentials delivered the same or next day, which the company believes are speed-critical items. Amazon ( AMZN ) said its everyday essentials selection grew more than twice as fast as all other categories in the U.S. during the first quarter.

The company noted that total items delivered on the same day or the next day after an order is up 30% year-to-date compared to the same period last year.

AMZN Price Action: Amazon ( AMZN ) shares were up 2.25% at $213.17 at the time of publication Tuesday, according to Benzinga Pro. Amazon ( AMZN ) stock is down about 3% year-to-date. Amazon ( AMZN ) has a 52-week high of $242.52 and a 52-week low of $151.61.

Read Next:

Why This Fidelity Fund Manager Is Buying China Tech Over The Magnificent Seven

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Moleculin Biotech Shares Rise After Announcing Preclinical Data for Annamycin Targeting Venetoclax-Resistant Leukemia
Moleculin Biotech Shares Rise After Announcing Preclinical Data for Annamycin Targeting Venetoclax-Resistant Leukemia
Dec 11, 2024
01:33 PM EST, 12/11/2024 (MT Newswires) -- Moleculin Biotech's ( MBRX ) shares were up nearly 9% in recent Wednesday trading after the company announced preclinical data showcasing its drug candidate Annamycin's efficacy against venetoclax-resistant acute myeloid leukemia, or AML, cell lines. Presented at the American Society of Hematology's Annual Meeting, the study showed that Annamycin effectively targets Cytarabine, or...
Comcast Business to Acquire Connectivity Services Provider Nitel From Cinven
Comcast Business to Acquire Connectivity Services Provider Nitel From Cinven
Dec 11, 2024
01:33 PM EST, 12/11/2024 (MT Newswires) -- Comcast ( CMCSA ) subsidiary Comcast Business said Wednesday it has agreed to acquire Nitel, a Chicago-based connectivity services provider, from private equity firm Cinven. Financial details weren't disclosed. Nitel provides network-as-a-service and managed solutions to 6,600 US enterprise customers in financial services, healthcare, and education industries. Price: 39.70, Change: +0.17, Percent Change:...
What's Going On With Moleculin Biotech Shares Wednesday?
What's Going On With Moleculin Biotech Shares Wednesday?
Dec 11, 2024
Moleculin Biotech, Inc. ( MBRX ) shares are trading higher on Wednesday after the company announced the online publication of preclinical data for its Annamycin Venetoclax Resistant AML model. What To Know: The preclinical data suggests that Annamycin effectively targets acute myeloid leukemia (AML) cell lines resistant to Cytarabine (Ara-C) and Venetoclax (VEN) in lab tests using cells from patients...
Sector Update: Consumer
Sector Update: Consumer
Dec 11, 2024
01:30 PM EST, 12/11/2024 (MT Newswires) -- Consumer stocks were mixed Wednesday afternoon with the Consumer Staples Select Sector SPDR Fund (XLP) fractionally lower and the Consumer Discretionary Select Sector SPDR Fund (XLY) rising 1.6%. In corporate news, Albertsons ( ACI ) terminated its planned $25 billion acquisition by Kroger ( KR ) after two courts ruled to block the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved